FutureChem Co Ltd
KOSDAQ:220100
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Easun Reyrolle Ltd
NSE:EASUNREYRL
|
IN |
FutureChem Co Ltd
Cash from Operating Activities
FutureChem Co Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Cash from Operating Activities
-₩2B
|
CAGR 3-Years
27%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Cash from Operating Activities
₩2.2T
|
CAGR 3-Years
33%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Cash from Operating Activities
-₩4.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Cash from Operating Activities
-₩20.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-24%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Cash from Operating Activities
₩14B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Cash from Operating Activities
-₩124.5B
|
CAGR 3-Years
-159%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
-31%
|
|
FutureChem Co Ltd
Glance View
FutureChem Co., Ltd. engages in the manufacture of medical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-08-13. Co.,Ltd is a Korea-based company principally engaged in the manufacture and distribution of radiopharmaceuticals. The firm manufactures radiopharmaceuticals including radiopharmaceuticals for diagnosis of various cancers such as lung cancer and for the early diagnosis of Parkinson's disease and Alzheimer's disease. The firm also produces medical automation modules such as cubes and disposable goods including disposable cassettes, reagent kits, radio-caps and kryptofix kits; productions of photon emission tomography (PET) and single photon emission computed tomography (SPECT) precursors for radiopharmaceuticals and other chemicals such as metal chelating agents, fluorescence probes, peptides.
See Also
What is FutureChem Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
-2B
KRW
Based on the financial report for Sep 30, 2025, FutureChem Co Ltd's Cash from Operating Activities amounts to -2B KRW.
What is FutureChem Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
11%
Over the last year, the Cash from Operating Activities growth was -30%. The average annual Cash from Operating Activities growth rates for FutureChem Co Ltd have been 27% over the past three years , 11% over the past five years .
